Immunovant, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Van Tuyl Christopher | Chief Legal Officer | Sale | 8,529 | $26.78 | $228,407 | 152,214 | Dec 18, 2025 |
| Roivant Sciences Ltd. | — | Purchase | 16,666,666 | $21.00 | $349,999,986 | 113,317,007 | Dec 12, 2025 |
| Fromkin Andrew J. | — | Sale | 2,898 | $23.95 | $69,407 | 85,852 | Dec 1, 2025 |
| Hughes Douglas J. | — | Sale | 1,909 | $23.96 | $45,740 | 120,773 | Dec 1, 2025 |
| Gloria Melanie | Chief Operating Officer | Sale | 2,375 | $23.97 | $56,929 | 173,511 | Nov 20, 2025 |
| Geffner Michael | Chief Medical Officer | Sale | 2,595 | $19.03 | $49,383 | 217,958 | Oct 22, 2025 |
| Stout Jay S | Chief Technology Officer | Sale | 2,520 | $19.03 | $47,956 | 200,814 | Oct 22, 2025 |
| Geffner Michael | Chief Medical Officer | Sale | 1,272 | $16.30 | $20,734 | 220,553 | Oct 8, 2025 |
| Stout Jay S | Chief Technology Officer | Sale | 1,585 | $16.30 | $25,836 | 203,334 | Oct 8, 2025 |
| Stout Jay S | Chief Technology Officer | Sale | 2,805 | $18.15 | $50,911 | 204,919 | Jul 23, 2025 |
| Geffner Michael | Chief Medical Officer | Sale | 2,385 | $18.15 | $43,288 | 221,825 | Jul 23, 2025 |
| Geffner Michael | Chief Medical Officer | Sale | 1,160 | $17.24 | $19,998 | 224,210 | Jul 9, 2025 |
| Stout Jay S | Chief Technology Officer | Sale | 1,519 | $17.24 | $26,188 | 207,724 | Jul 9, 2025 |
| Girao Tiago | Chief Financial Officer | Award / Grant | 208,388 | — | — | 208,388 | May 1, 2025 |
| Bauer Jake | — | Award / Grant | 25,016 | — | — | 25,016 | May 1, 2025 |
| Susman Robert Graham | — | Award / Grant | 25,016 | — | — | 25,016 | May 1, 2025 |
| Stout Jay S | Chief Technology Officer | Sale | 1,925 | $14.79 | $28,471 | 209,243 | Apr 23, 2025 |
| Geffner Michael | Chief Medical Officer | Sale | 2,349 | $14.79 | $34,742 | 225,370 | Apr 23, 2025 |
| Barnett Eva Renee | Chief Financial Officer | Sale | 2,993 | $14.89 | $44,566 | 396,774 | Apr 16, 2025 |
| Salzmann Peter | Chief Executive Officer | Sale | 8,321 | $14.89 | $123,900 | 1,178,191 | Apr 16, 2025 |
| Stout Jay S | Chief Technology Officer | Sale | 5,004 | $12.99 | $65,002 | 211,168 | Apr 9, 2025 |
| Geffner Michael | Chief Medical Officer | Sale | 6,169 | $12.99 | $80,135 | 227,719 | Apr 9, 2025 |
| Barnett Eva Renee | Chief Financial Officer | Sale | 4,050 | $12.99 | $52,610 | 399,767 | Apr 9, 2025 |
| Salzmann Peter | Chief Executive Officer | Sale | 28,094 | $12.99 | $364,941 | 1,186,512 | Apr 9, 2025 |
| Van Tuyl Christopher | Chief Legal Officer | Award / Grant | 50,787 | — | — | 160,743 | Apr 1, 2025 |
| Gloria Melanie | Chief Operating Officer | Award / Grant | 76,181 | — | — | 186,137 | Apr 1, 2025 |
| Stout Jay S | Chief Technology Officer | Award / Grant | 76,181 | — | — | 216,172 | Apr 1, 2025 |
| Geffner Michael | Chief Medical Officer | Award / Grant | 101,574 | — | — | 233,888 | Apr 1, 2025 |
| Barnett Eva Renee | Chief Financial Officer | Award / Grant | 88,878 | — | — | 410,830 | Apr 1, 2025 |
| Salzmann Peter | Chief Executive Officer | Award / Grant | 265,820 | — | — | 1,214,606 | Apr 1, 2025 |
| Pande Atul | — | Award / Grant | 16,188 | — | — | 102,851 | Apr 1, 2025 |
| Hughes Douglas J. | — | Award / Grant | 16,188 | — | — | 135,773 | Apr 1, 2025 |
| Fromkin Andrew J. | — | Award / Grant | 16,188 | — | — | 108,101 | Apr 1, 2025 |
| MIGAUSKY GEORGE V | — | Award / Grant | 16,188 | — | — | 137,251 | Apr 1, 2025 |
| Torti Frank | — | Award / Grant | 199,365 | — | — | 835,039 | Apr 1, 2025 |
| Fromkin Andrew J. | — | Sale | 1,384 | $19.96 | $27,625 | 91,913 | Mar 7, 2025 |
| Macias William L. | Chief Medical Officer | Sale | 2,055 | $20.86 | $42,867 | 357,353 | Feb 19, 2025 |
| Barnett Eva Renee | Chief Financial Officer | Sale | 2,814 | $20.86 | $58,700 | 321,952 | Feb 19, 2025 |
| Salzmann Peter | Chief Executive Officer | Sale | 15,439 | $20.86 | $322,058 | 948,786 | Feb 19, 2025 |
| Stout Jay S | Chief Technology Officer | Sale | 2,195 | $23.59 | $51,780 | 139,991 | Jan 22, 2025 |
| Geffner Michael | Chief Medical Officer | Sale | 2,657 | $23.59 | $62,679 | 132,314 | Jan 22, 2025 |
| Macias William L. | Chief Medical Officer | Sale | 387 | $23.81 | $9,214 | 359,427 | Jan 15, 2025 |
| Barnett Eva Renee | Chief Financial Officer | Sale | 109 | $24.19 | $2,637 | 324,766 | Jan 15, 2025 |
| Salzmann Peter | Chief Executive Officer | Sale | 8,352 | $23.81 | $198,861 | 964,640 | Jan 15, 2025 |
| Roivant Sciences Ltd. | — | Purchase | 16,845,010 | $20.00 | $336,900,200 | 96,650,341 | Jan 13, 2025 |
| Barnett Eva Renee | Chief Financial Officer | Sale | 4,105 | $24.10 | $98,931 | 327,064 | Jan 8, 2025 |
| Salzmann Peter | Chief Executive Officer | Sale | 5,105 | $24.10 | $123,031 | 972,992 | Jan 8, 2025 |
| Van Tuyl Christopher | Chief Legal Officer | Award / Grant | 109,956 | — | — | 109,956 | Dec 16, 2024 |
| Pande Atul | — | Sale | 7,750 | $28.54 | $221,185 | 86,663 | Dec 2, 2024 |
| Hughes Douglas J. | — | Sale | 5,425 | $28.54 | $154,830 | 119,585 | Dec 2, 2024 |